Mersana Therapeutics Inc. (MRSN)
NASDAQ: MRSN
· Real-Time Price · USD
0.36
-0.01 (-2.44%)
At close: Jun 05, 2025, 3:59 PM
0.36
-0.25%
Pre-market: Jun 06, 2025, 08:34 AM EDT
-2.44% (1D)
| Bid | 0.35 |
| Market Cap | 45.48M |
| Revenue (ttm) | 34.01M |
| Net Income (ttm) | -74.01M |
| EPS (ttm) | -0.59 |
| PE Ratio (ttm) | -0.62 |
| Forward PE | -0.62 |
| Analyst | Buy |
| Ask | 0.37 |
| Volume | 1,118,445 |
| Avg. Volume (20D) | 2,857,385 |
| Open | 0.36 |
| Previous Close | 0.37 |
| Day's Range | 0.36 - 0.39 |
| 52-Week Range | 0.26 - 2.83 |
| Beta | 0.82 |
About MRSN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRSN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MRSN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-17.24%
Mersana Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
4 months ago
-44.62%
Mersana Therapeutics shares are trading lower. The company announced initial clinical data from the Phase 1 dose escalation and backfill cohorts for emiltatug ledadotin.
3 weeks ago · seekingalpha.com
Mersana Therapeutics, Inc. (MRSN) Q1 2025 Earnings Call TranscriptMersana Therapeutics, Inc. (NASDAQ:MRSN ) Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ET Company Participants Jason Fredette - Senior Vice President, Investor Relations & Corporate Communica...
